{"disease":{"id":"connective-tissue","name":"connective tissue"},"drugs":{"marketed":[{"drug_id":"yondelis","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Yondelis","company_name":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","drug_phase":"marketed","molecular_target":"Proto-oncogene tyrosine-protein kinase Src, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"trabectedin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yondelis","generic_name":"TRABECTEDIN","company_name":"Janssen Prods","drug_phase":"marketed","molecular_target":"Proto-oncogene tyrosine-protein kinase Src","drug_class":"Alkylating Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Yondelis works by binding to DNA and causing interstrand crosslinks, thereby inhibiting cancer cell growth."},{"drug_id":"adriacin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"adriacin","company_name":"Chipscreen Biosciences, Ltd.","drug_phase":"phase_1","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxydaunorubicin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxydaunorubicin","company_name":"University of Colorado, Denver","drug_phase":"phase_2","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"liposomal-doxorubicin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Liposomal Doxorubicin","generic_name":"liposomal-doxorubicin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase","drug_class":"doxorubicin","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"doxorubicin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Doxorubicin Hydrochloride","generic_name":"doxorubicin","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Aurora kinase A","drug_class":"Anthracycline Topoisomerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division."},{"drug_id":"hydroxydaunomycin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxydaunomycin","company_name":"Weill Medical College of Cornell University","drug_phase":"phase_2","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adriamycin","indication_name":"Soft or Connective Tissue Sarcoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adriamycin","company_name":"Johann Wolfgang Goethe University Hospital","drug_phase":"marketed","molecular_target":"Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 6, 72 kDa type IV collagenase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03847753","title":"Exploring the Comorbidity Between Mental Disorders and General Medical Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":5940299,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT07217522","title":"Rutgers University Study of the Genetics of Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Rutgers, The State University of New Jersey","has_results":false},{"nct_id":"NCT07477197","title":"Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04896138","title":"University of Virginia Natural History Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT07506967","title":"Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2420,"lead_sponsor_name":"Kenya Medical Research Institute","has_results":false},{"nct_id":"NCT02677961","title":"An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05179824","title":"Tempus Priority Study: A Pan-tumor Observational Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Tempus AI","has_results":false},{"nct_id":"NCT06499233","title":"Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT00341679","title":"Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT03626688","title":"A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"United Therapeutics","has_results":false},{"nct_id":"NCT01208792","title":"Auto-immunity and Pulmonary Arterial Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":629,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03430388","title":"Yellow Fever Vaccine in Patients With Rheumatic Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06716606","title":"A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":514,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05980728","title":"Connective Tissue Disease Patients With Pulmonary Hypertension","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05516758","title":"A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":491,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT00001978","title":"Determination of Kidney Function","phase":"","overall_status":"TERMINATED","enrollment_count":456,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03565601","title":"Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52)","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05961267","title":"Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism","phase":"","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06702228","title":"Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Royal College of Surgeons, Ireland","has_results":false},{"nct_id":"NCT07329556","title":"Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Bursa City Hospital","has_results":false},{"nct_id":"NCT01143493","title":"The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":278,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT06462768","title":"Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"CHU de Reims","has_results":false},{"nct_id":"NCT05715203","title":"Aortic Stiffness in Patients With Genetic Aortopathies","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"IRCCS Policlinico S. Donato","has_results":false},{"nct_id":"NCT03951272","title":"The Efficacy and Safety of Lyoplant® Onlay in Repairing Cerebral Dura Mater","phase":"NA","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"B. Braun Medical International Trading Company Ltd.","has_results":false},{"nct_id":"NCT06732674","title":"Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":218,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT02657356","title":"Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":202,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT07180537","title":"Creating Health Course Study for People With Rheumatological Conditions","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Terry L. Wahls","has_results":false},{"nct_id":"NCT04928586","title":"Immunosuppressant Combined With Pirfenidone in CTD-ILD","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT07400133","title":"Assessing Feasibility of a Digital Health Intervention for Multiple Long-Term Condition Care in Primary Health Settings in India and Nepal","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Centre for Chronic Disease Control, India","has_results":false},{"nct_id":"NCT00076830","title":"Evaluation and Treatment of Patients With Connective Tissue Disease","phase":"","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT07486206","title":"Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT06779799","title":"Characterization of \"Bamboo\" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT07184814","title":"Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT02198651","title":"A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05892016","title":"Ridge Preservation Using Different Techniques","phase":"NA","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"Tri-Service General Hospital","has_results":false},{"nct_id":"NCT04918524","title":"The Clinical Features and Pregnancy Outcomes of CTD Patients","phase":"","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT04095351","title":"Connective Tissue Diseases and Lung Manifestations","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT05505409","title":"Efficacy and Safety of Pirfenidone in CTD-ILD","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT05715463","title":"Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":101,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07319598","title":"A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06427889","title":"Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"Malmö University","has_results":false},{"nct_id":"NCT04915482","title":"TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":94,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07482917","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT07547592","title":"Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT04910126","title":"Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":84,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05462574","title":"Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)","phase":"","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT07437417","title":"A Novel Volume Stable Matrix for Gingival Recession Coverage at Teeth","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Bern","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}